{"cik":1322505,"taxonomy":"us-gaap","tag":"InventoryNet","label":"Inventory, Net","description":"Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.","entityName":"ALBIREO PHARMA, INC.","units":{"USD":[{"end":"2021-09-30","val":196000,"accn":"0001558370-21-014469","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-04","frame":"CY2021Q3I"},{"end":"2021-12-31","val":194000,"accn":"0001558370-22-002501","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-01"},{"end":"2021-12-31","val":194000,"accn":"0001558370-22-008984","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-16"},{"end":"2021-12-31","val":194000,"accn":"0001558370-22-013652","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15"},{"end":"2021-12-31","val":194000,"accn":"0001558370-22-016893","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-08","frame":"CY2021Q4I"},{"end":"2022-03-31","val":1821000,"accn":"0001558370-22-008984","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-16","frame":"CY2022Q1I"},{"end":"2022-06-30","val":2096000,"accn":"0001558370-22-013652","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15","frame":"CY2022Q2I"},{"end":"2022-09-30","val":3149000,"accn":"0001558370-22-016893","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-08","frame":"CY2022Q3I"}]}}